Tibor Gajdics
Director/Board Member at GOLDEN AGE EXPLORATION LTD.
Net worth: 43 112 $ as of 29/04/2024
Profile
Tibor Fancis Gajdics is currently the Chairman & President at KOP Therapeutics Corp.
since 2021 and an Independent Director at Golden Age Exploration Ltd.
since 2022.
Previously, he worked as a Director at TAAL Distributed Information Technologies, Inc. in 2018 and as the Vice President-Corporate Development at Southstone Minerals Ltd.
from 2012 to 2013.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
GOLDEN AGE EXPLORATION LTD.
10.46% | 25/07/2023 | 1,077,801 ( 10.46% ) | 43 112 $ | 29/04/2024 |
Tibor Gajdics active positions
Companies | Position | Start |
---|---|---|
GOLDEN AGE EXPLORATION LTD. | Director/Board Member | 23/02/2021 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | Chairman | 30/11/2021 |
Former positions of Tibor Gajdics
Companies | Position | End |
---|---|---|
TAAL DISTRIBUTED INFORMATION TECHNOLOGIES INC. | Chief Executive Officer | 25/03/2018 |
SOUTHSTONE MINERALS LIMITED | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SOUTHSTONE MINERALS LIMITED | Non-Energy Minerals |
Private companies | 3 |
---|---|
Taal Distributed Information Technologies, Inc.
Taal Distributed Information Technologies, Inc. Packaged SoftwareTechnology Services Taal Distributed Information Technologies, Inc. operates and manages blockchain infrastructure to solve complex computation problems to validate transactions on various blockchains. Its services include transaction processing, processing power, and TAAL console. The company was founded on March 11, 2011 and is headquartered in Toronto, Canada. | Technology Services |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | Health Technology |
Golden Age Exploration Ltd. |
- Stock Market
- Insiders
- Tibor Gajdics